5 research outputs found
Detection of Helicobacter pylori in stool specimens by non-invasive antigen enzyme immunoassay in children: multicentre Italian study. (I.F.5.331)
Double versus triple therapy for childhood Helicobacter pylori Gastritis. A double blind multicentre trial.
Dual vsTriple Therapy for Childhood Helicobacter pylori Gastritis: a Double-Blind Randomized Multicentre Trial. (I.F. 2.313)
Background. Data on the efficacy of eradication
treatment for Helicobacter pylori gastritis in children
are scarce.
Aim. To evaluate the efficacy of triple therapy with
lansoprazole plus amoxicillin and tinidazole vs. dual
therapy with amoxicillin and tinidazole in a doubleblind
randomized multicentre trial, and the usefulness
of eradication in terms of long-term symptom resolution.
Subjects. We enrolled 43 consecutive children undergoing
endoscopy for upper gastrointestinal dyspepsia
with H. pylori gastritis. They underwent a 13C-urea
breath test, completed a 2-week symptom diary card,
and were randomized. Treatment was given in a
Redidose box (Redidose Company Ltd., Brighton, UK)
containing either lansoprazole-amoxicillin-tinidazole
(triple therapy) or placebo plus amoxicillin-tinidazole
(dual therapy) for 1 week. The completion of a 2-
week symptom diary card and the performance of
a breath test were repeated 6 weeks and 6 months
after the end of therapy. One to two years later, a
structured telephone interview was conducted with
36 of the children.
Results. According to the breath test, 6 weeks after
the end of therapy H. pylori was eradicated in 15 of
22 children on triple therapy [68.2%; 95% confidence
interval (CI) = 45–88] and in 15 of 21 children on dual
therapy (71%; 95% CI = 48–89; not significant), and
6 months after the end of therapy it was eradicated
in 16 of 22 children on triple therapy (72.7%) and in
15 of 21 children on dual therapy. Six months after
therapy, symptoms were analysed in 11 H. pyloripositive
and 31 H. pylori-negative children, and it
was found that dyspeptic symptoms had disappeared
or improved in both groups, with no difference
between them. One to two years later, 36 children were
interviewed. Epigastric pain had recurred in three of
26 H. pylori-negative and in seven of 10 H. pyloripositive
children ( p = .001); in three of the latter, pain
was severe and required additional treatment.
Conclusion. One-week triple or dual therapy with
two antibiotics achieved similar eradication rates. Soon
after treatment, symptoms disappeared or improved
in most children irrespective of eradication, but
epigastric pain recurred in the majority of the stillinfected
children within 2 years.
Keywords. Helicobacter pylori, childhood gastritis,
triple therapy, dual therapy, double blind trial,
dyspepsia, epigastric pain, clinica pediatrica
